CASI Pharmaceuticals, Inc (DE)
CASIDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000895051
CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in CASI Pharmaceuticals, Inc (DE) as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q2 2022
- Shares held
- 1.99M
- −200.1K (−9.1%) vs. Q2 2022
- Total value
- $5.17M
- −$1.09M (−17.4%) vs. Q2 2022
- New holders
- 6
- 4 more added
- Sold out
- 6
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 23 | $3.31M |
| Q3 2022 | 24 | $5.17M |
| Q2 2022 | 24 | $6.26M |
| Q1 2022 | 45 | $18.9M |
| Q4 2021 | 51 | $22.4M |
| Q3 2021 | 59 | $46.0M |
| Q2 2021 | 69 | $72.3M |
| Q1 2021 | 86 | $127.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc (DE); share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 1,015,000 | $2.64M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 257,443 | $669.0K | 0.00% | −48,689−15.9% | Reduced |
| Wellington Shields Capital Management, LLC | 218,247 | $567.0K | 0.13% | +4,997+2.3% | Added |
| Wellington Shields & Co., LLC | 145,315 | $378.0K | 0.16% | −20.0% | Reduced |
| Geode Capital Management, LLC | 98,308 | $255.0K | 0.00% | −16,886−14.7% | Reduced |
| BlackRock Inc. | 91,714 | $239.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 35,555 | $92.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 33,637 | $87.0K | 0.00% | +33,637 | New |
| Northern Trust Corp | 25,593 | $67.0K | 0.00% | −4,073−13.7% | Reduced |
| Franklin Resources Inc | 24,546 | $64.0K | 0.00% | +243+1.0% | Added |
| Dimensional Fund Advisors LP | 11,508 | $30.0K | 0.00% | −1,697−12.9% | Reduced |
| Prudential Financial Inc | 11,000 | $29.0K | 0.00% | +11,000 | New |
| Renaissance Technologies LLC | 10,400 | $27.0K | 0.00% | +10,400 | New |
| Morgan Stanley | 3,975 | $10.0K | 0.00% | +1,664+72.0% | Added |
| UBS Group AG | 3,089 | $8.00K | 0.00% | +3,089 | New |
| Tower Research Capital LLC (TRC) | 2,305 | $6.00K | 0.00% | +248+12.1% | Added |
| Advisor Group Holdings, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 134 | $348 | 0.00% | +134 | New |
| JPMorgan Chase & Co | 25 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 60 | $0 | 0.00% | −15−20.0% | Reduced |
| Royal Bank of Canada | 18 | $0 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 13 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 9 | – | – | +9 | New |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −132,014−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −31,530−100.0% | Sold out |
| RBF Capital, LLC | 0 | $0 | 0.00% | −15,936−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −11,686−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −2,797−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −150−100.0% | Sold out |